Presentation

A conference organized by European Medicines Agency (EMA) and Medicines and Medical Devices Agency of Serbia (ALIMS) entitled: “Reinforcing Communication to Patients and Healthcare Professionals” was held in Belgrade, on 23rd June 2014 as part of the project in the scope of Instrument for Pre-accession Assistance (IPA) of the European Union


  1. 9.40 P ZELIC – Introduction to ALIMS
  2. 10.00 G DANIELSSON – Oversight of Clinical Trials in Europe- Member State perspective
  3. 10.20 T SPATHOPOULOU – Oversight of Clinical Trials in the EU-EMA perspective
  4. 10.40 N DEDES – Norms related to Ethical CT-A Patients Perspective
  5. 11.30 A SEGEC – Pharmacovigilance in the European Union
  6. 12.15 J RAINE – The role of PRAC in – Pharmacovigilance Decisions
  7. 12.25 J RAINE – Pharmacovigilance requirements for Member States
  8. 12.35 J GARCIA & J RAINE – Safety communication and its role in risk minimisation
  9. 14 30 I MOULON – Cooperation between EMA and patients and healthcare professionals organisations
  10. 14.45 D HAERRY – Overview of EMA s interaction with patients and consumers organisations (2013)
  11. 15.00 G CALVO – Interaction with healthcare professionals-Overview of involvement in EMA activities during 2013
  12. 15.15 D BONNET – Reinforcing the collaboration with healthcare professionals and patient associations-ANSM
  13. 15.30 F HOUYEZ – Supply shortages of medicines in Europe
  14. 16.20 I VANEVSKI – ALIMS Web portal
  15. 16.50 J GARCIA – Communication to patients, consumers and healthcare professionals